Ultragenyx制药

RARE

----

主要股东最新
股东
BlackRock, Inc.	10.84%	1,065.43 万	3.40%	+335.47 万	2026/06/30
RTW Investments, LP	7.93%	779.69 万	4.21%	+414.81 万	2026/06/30
Vanguard Portfolio Management, LLC	6.91%	679.01 万	1.42%	+140.41 万	2026/06/30
AQR Capital Management, LLC	6.65%	653.40 万	2.00%	+197.27 万	2026/06/30
State Street Investment Management	6.27%	615.88 万	1.15%	+113.73 万	2026/06/30
Vanguard Capital Management, LLC	5.05%	496.79 万	0.16%	+16.99 万	2026/06/30
Two Sigma Investments, LP	3.68%	362.12 万	1.44%	+141.54 万	2026/06/30
Sands Capital Management, LLC	3.21%	315.84 万	0.06%	-5.62 万	2026/06/30
Jacobs Levy Equity Management Inc	2.99%	293.97 万	1.53%	+150.86 万	2026/06/30
Frontier Capital Management Co LLC	2.90%	284.79 万	0.66%	+65.68 万	2026/06/30
Emil KakkisFounder, President, CEO & Director	2.80%	275.48 万	0.62%	+61.36 万	2026/04/16
Geode Capital Management, LLC	2.62%	257.88 万	0.74%	+72.94 万	2026/06/30
Bellevue Asset Management AG	2.02%	198.28 万	0.41%	-39.72 万	2026/06/30
D. E. Shaw & Co., L.P.	1.76%	173.02 万	0.48%	+46.92 万	2026/06/30
Sofinnova Investments, Inc.	1.75%	171.75 万	1.46%	-142.84 万	2026/06/30
Adage Capital Management, L.P.	1.61%	158.00 万	1.12%	+110.00 万	2026/06/30
GW&K Investment Management, LLC	1.51%	148.12 万	0.14%	-13.42 万	2026/06/30
MPM BioImpact LLC	1.44%	141.82 万	1.44%	+141.82 万	2026/06/30
T. Rowe Price Group, Inc.	1.38%	135.65 万	0.56%	+55.24 万	2026/06/30
Wellington Management Group LLP	1.27%	125.05 万	1.42%	-139.03 万	2026/06/30

全部股东